247 related articles for article (PubMed ID: 34512669)
1. Pharmacological Inhibition of STAT6 Ameliorates Myeloid Fibroblast Activation and Alternative Macrophage Polarization in Renal Fibrosis.
Jiao B; An C; Tran M; Du H; Wang P; Zhou D; Wang Y
Front Immunol; 2021; 12():735014. PubMed ID: 34512669
[TBL] [Abstract][Full Text] [Related]
2. STAT6 Deficiency Attenuates Myeloid Fibroblast Activation and Macrophage Polarization in Experimental Folic Acid Nephropathy.
Jiao B; An C; Du H; Tran M; Wang P; Zhou D; Wang Y
Cells; 2021 Nov; 10(11):. PubMed ID: 34831280
[TBL] [Abstract][Full Text] [Related]
3. JAK3/STAT6 Stimulates Bone Marrow-Derived Fibroblast Activation in Renal Fibrosis.
Yan J; Zhang Z; Yang J; Mitch WE; Wang Y
J Am Soc Nephrol; 2015 Dec; 26(12):3060-71. PubMed ID: 26032813
[TBL] [Abstract][Full Text] [Related]
4. The IL-4 receptor α has a critical role in bone marrow-derived fibroblast activation and renal fibrosis.
Liang H; Zhang Z; Yan J; Wang Y; Hu Z; Mitch WE; Wang Y
Kidney Int; 2017 Dec; 92(6):1433-1443. PubMed ID: 28739140
[TBL] [Abstract][Full Text] [Related]
5. Jumonji domain-containing protein-3 (JMJD3) promotes myeloid fibroblast activation and macrophage polarization in kidney fibrosis.
An C; Jiao B; Du H; Tran M; Song B; Wang P; Zhou D; Wang Y
Br J Pharmacol; 2023 Sep; 180(17):2250-2265. PubMed ID: 37076137
[TBL] [Abstract][Full Text] [Related]
6. Jmjd3/IRF4 axis aggravates myeloid fibroblast activation and m2 macrophage to myofibroblast transition in renal fibrosis.
Liang H; Liu B; Gao Y; Nie J; Feng S; Yu W; Wen S; Su X
Front Immunol; 2022; 13():978262. PubMed ID: 36159833
[TBL] [Abstract][Full Text] [Related]
7. Iguratimod prevents renal fibrosis in unilateral ureteral obstruction model mice by suppressing M2 macrophage infiltration and macrophage-myofibroblast transition.
Zhou Y; Li Z; Yu S; Wang X; Xie T; Zhang W
Ren Fail; 2024 Dec; 46(1):2327498. PubMed ID: 38666363
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological targeting of BET proteins inhibits renal fibroblast activation and alleviates renal fibrosis.
Xiong C; Masucci MV; Zhou X; Liu N; Zang X; Tolbert E; Zhao TC; Zhuang S
Oncotarget; 2016 Oct; 7(43):69291-69308. PubMed ID: 27732564
[TBL] [Abstract][Full Text] [Related]
9. Glycolysis inhibitors suppress renal interstitial fibrosis via divergent effects on fibroblasts and tubular cells.
Wei Q; Su J; Dong G; Zhang M; Huo Y; Dong Z
Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1162-F1172. PubMed ID: 30969803
[TBL] [Abstract][Full Text] [Related]
10. Twist1 in Infiltrating Macrophages Attenuates Kidney Fibrosis
Ren J; Zhang J; Rudemiller NP; Griffiths R; Wen Y; Lu X; Privratsky JR; Gunn MD; Crowley SD
J Am Soc Nephrol; 2019 Sep; 30(9):1674-1685. PubMed ID: 31315922
[TBL] [Abstract][Full Text] [Related]
11. Delayed treatment with erythropoietin attenuates renal fibrosis in mouse model of unilateral ureteral obstruction.
Nishida A; Nishida M; Iehara T
Int J Urol; 2024 Jun; 31(6):685-692. PubMed ID: 38366861
[TBL] [Abstract][Full Text] [Related]
12. Protein arginine methyltransferase 1 mediates renal fibroblast activation and fibrogenesis through activation of Smad3 signaling.
Zhu Y; Yu C; Zhuang S
Am J Physiol Renal Physiol; 2020 Feb; 318(2):F375-F387. PubMed ID: 31813251
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid signaling through its receptor initiates profibrotic epithelial cell fibroblast communication mediated by epithelial cell derived connective tissue growth factor.
Sakai N; Chun J; Duffield JS; Lagares D; Wada T; Luster AD; Tager AM
Kidney Int; 2017 Mar; 91(3):628-641. PubMed ID: 27927603
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen-like protein 2 deficiency aggravates renal fibrosis by facilitating macrophage polarization.
Wu S; Li M; Xu F; Li GQ; Han B; He XD; Li SJ; He QH; Lai XY; Zhou S; Zheng QY; Guo B; Chen J; Zhang KQ; Xu GL
Biomed Pharmacother; 2020 Oct; 130():110468. PubMed ID: 32795921
[TBL] [Abstract][Full Text] [Related]
15. A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy.
Pang M; Ma L; Gong R; Tolbert E; Mao H; Ponnusamy M; Chin YE; Yan H; Dworkin LD; Zhuang S
Kidney Int; 2010 Aug; 78(3):257-68. PubMed ID: 20520592
[TBL] [Abstract][Full Text] [Related]
16. Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis.
Yan Y; Ma L; Zhou X; Ponnusamy M; Tang J; Zhuang MA; Tolbert E; Bayliss G; Bai J; Zhuang S
Kidney Int; 2016 Jan; 89(1):68-81. PubMed ID: 26444028
[TBL] [Abstract][Full Text] [Related]
17. Apamin inhibits renal fibrosis via suppressing TGF-β1 and STAT3 signaling in vivo and in vitro.
Gwon MG; An HJ; Gu H; Kim YA; Han SM; Park KK
J Mol Med (Berl); 2021 Sep; 99(9):1265-1277. PubMed ID: 34031696
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice.
Singh SP; Tao S; Fields TA; Webb S; Harris RC; Rao R
Dis Model Mech; 2015 Aug; 8(8):931-40. PubMed ID: 26092126
[TBL] [Abstract][Full Text] [Related]
19. H
Zhou Y; Zhu X; Wang X; Peng Y; Du J; Yin H; Yang H; Ni X; Zhang W
Exp Cell Res; 2020 Feb; 387(1):111779. PubMed ID: 31846625
[TBL] [Abstract][Full Text] [Related]
20. A STAT6 Inhibitor AS1517499 Reduces Preventive Effects of Apoptotic Cell Instillation on Bleomycin-Induced Lung Fibrosis by Suppressing PPARγ.
Kim MJ; Lee YJ; Yoon YS; Lim JH; Park EM; Chong YH; Kang JL
Cell Physiol Biochem; 2018; 45(5):1863-1877. PubMed ID: 29510393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
